OCUL
Price
$12.94
Change
+$0.24 (+1.89%)
Updated
Sep 3 closing price
Capitalization
2.25B
67 days until earnings call
TARS
Price
$57.72
Change
-$0.87 (-1.48%)
Updated
Sep 3 closing price
Capitalization
2.44B
62 days until earnings call
Interact to see
Advertisement

OCUL vs TARS

Header iconOCUL vs TARS Comparison
Open Charts OCUL vs TARSBanner chart's image
Ocular Therapeutix
Price$12.94
Change+$0.24 (+1.89%)
Volume$4.53M
Capitalization2.25B
Tarsus Pharmaceuticals
Price$57.72
Change-$0.87 (-1.48%)
Volume$750.23K
Capitalization2.44B
OCUL vs TARS Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. TARS commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Buy and TARS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (OCUL: $12.94 vs. TARS: $57.72)
Brand notoriety: OCUL and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 210% vs. TARS: 119%
Market capitalization -- OCUL: $2.25B vs. TARS: $2.44B
OCUL [@Biotechnology] is valued at $2.25B. TARS’s [@Biotechnology] market capitalization is $2.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, both OCUL and TARS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 3 TA indicator(s) are bullish while TARS’s TA Score has 6 bullish TA indicator(s).

  • OCUL’s TA Score: 3 bullish, 5 bearish.
  • TARS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TARS is a better buy in the short-term than OCUL.

Price Growth

OCUL (@Biotechnology) experienced а +5.03% price change this week, while TARS (@Biotechnology) price change was -0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

OCUL is expected to report earnings on Nov 10, 2025.

TARS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TARS($2.44B) has a higher market cap than OCUL($2.25B). OCUL YTD gains are higher at: 51.522 vs. TARS (5.815). TARS has higher annual earnings (EBITDA): -81.71M vs. OCUL (-200.5M). OCUL (391M) and TARS (381M) have equal amount of cash in the bank . TARS has less debt than OCUL: TARS (72.4M) vs OCUL (76.9M). TARS has higher revenues than OCUL: TARS (296M) vs OCUL (56.7M).
OCULTARSOCUL / TARS
Capitalization2.25B2.44B92%
EBITDA-200.5M-81.71M245%
Gain YTD51.5225.815886%
P/E RatioN/AN/A-
Revenue56.7M296M19%
Total Cash391M381M103%
Total Debt76.9M72.4M106%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCULTARS
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWOCX49.670.18
+0.36%
MFS Global Growth C
HGXSX17.210.01
+0.06%
Hartford Global Impact R4
FOKFX28.07N/A
N/A
Fidelity OTC K6
JDVPX24.69-0.07
-0.28%
JHancock Disciplined Value R2
WWSCX17.66-0.06
-0.34%
Keeley Small Cap Fund C

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+1.89%
EYPT - OCUL
65%
Loosely correlated
+2.30%
RVMD - OCUL
55%
Loosely correlated
+0.61%
CRNX - OCUL
55%
Loosely correlated
+4.05%
IDYA - OCUL
55%
Loosely correlated
+1.10%
DNLI - OCUL
55%
Loosely correlated
-0.91%
More

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with CRNX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
+0.02%
CRNX - TARS
39%
Loosely correlated
+7.45%
RYTM - TARS
38%
Loosely correlated
+1.03%
OCUL - TARS
38%
Loosely correlated
+4.01%
XERS - TARS
38%
Loosely correlated
+1.15%
XENE - TARS
36%
Loosely correlated
+1.52%
More